Press Coverage

Ash Biomedical’s Managing Director, Ade Shodeinde, authored a widely read op-ed published on LinkedIn Pulse responding to the national conversation around GlaxoSmithKline’s exit from Nigeria. The article argued that the departure of multinationals represents an opportunity — not a setback — for homegrown manufacturers like Ash Biomedical, who are already building the infrastructure for end-to-end […]

ThisDay — Nigeria’s most widely read national newspaper — cited Ash Biomedical Diagnostics Ltd as a trailblazer in the country’s emerging local diagnostics manufacturing sector. The article, written in response to the national debate around GSK’s exit from Nigeria, noted that companies like Ash Biomedical “stand alone” in developing and manufacturing affordable, high-quality in-vitro diagnostics